R
Ralph A. Bundschuh
Researcher at University Hospital Bonn
Publications - 93
Citations - 2481
Ralph A. Bundschuh is an academic researcher from University Hospital Bonn. The author has contributed to research in topics: Medicine & Prostate cancer. The author has an hindex of 20, co-authored 68 publications receiving 1881 citations.
Papers
More filters
Journal ArticleDOI
Tissue Classification as a Potential Approach for Attenuation Correction in Whole-Body PET/MRI: Evaluation with PET/CT Data
Axel Martinez-Möller,Michael Souvatzoglou,Gaspar Delso,Ralph A. Bundschuh,Christophe Chefd'hotel,Sibylle Ziegler,Nassir Navab,Markus Schwaiger,Stephan G. Nekolla +8 more
TL;DR: A segmented attenuation map with 4 classes derived from CT data had only a small effect on the SUVs of 18F-FDG–avid lesions and did not change the interpretation for any patient, and appears to be practical and valid for MRI-based AC.
Journal ArticleDOI
Theranostics in nuclear medicine practice.
Anna Yordanova,Elisabeth Eppard,Stefan Kürpig,Ralph A. Bundschuh,Stefan Schönberger,Maria A. Gonzalez-Carmona,Georg Feldmann,Hojjat Ahmadzadehfar,Markus Essler +8 more
TL;DR: The aim of this review was to provide a summary of background knowledge and current applications, and to identify the advantages of targeted therapies and imaging in nuclear medicine practices.
Journal ArticleDOI
Textural Parameters of Tumor Heterogeneity in 18F-FDG PET/CT for Therapy Response Assessment and Prognosis in Patients with Locally Advanced Rectal Cancer
Ralph A. Bundschuh,Julia Dinges,Larissa Neumann,Martin Seyfried,Norbert Zsoter,Laszlo Papp,Robert D. Rosenberg,Karen Becker,Sabrina T. Astner,Martin Henninger,Ken Herrmann,Sibylle Ziegler,Markus Schwaiger,Markus Essler +13 more
TL;DR: Tumor heterogeneity assessed by the COV, being superior to the investigated conventional parameters, is an important predictive factor in patients with rectal cancer and can provide prognostic information.
Journal ArticleDOI
The sensitivity of [11C]choline PET/CT to localize prostate cancer depends on the tumor configuration.
Michael Souvatzoglou,Gregor Weirich,Sarah Schwarzenboeck,Tobias Maurer,Tibor Schuster,Ralph A. Bundschuh,Matthias Eiber,Ken Herrmann,Hubert R. Kuebler,Hans Wester,Heinz Hoefler,Juergen E. Gschwend,Markus Schwaiger,Uwe Treiber,Bernd J. Krause +14 more
TL;DR: The detection and localization of PCa in the prostate with [11C]choline PET/CT is impaired by tumor configuration, and in the patient population, PCa tissue could not be distinguished from benign pathologies inThe prostate.
Journal ArticleDOI
Clinical Translation and First In-Human Use of [44Sc]Sc-PSMA-617 for PET Imaging of Metastasized Castrate-Resistant Prostate Cancer.
Elisabeth Eppard,Ana de la Fuente,Martina Benešová,Ambreen Khawar,Ralph A. Bundschuh,Florian C. Gärtner,Barbara Kreppel,Klaus Kopka,Markus Essler,Frank Rösch +9 more
TL;DR: The synthesis of [44Sc]Sc-PSMA-617 as radiopharmaceutical with generator produced scandium-44, its in vitro characterization and clinical translation as part of a first in-human study are reported.